[spacer image]
BD
BD - Worldwide
Select Another Location
[spacer image] [spacer image] Physicians [spacer image] Labs [spacer image]
[spacer image] [spacer image]
TriPath
[spacer image]
Cervical Cytology
[spacer image]
Molecular Oncology BD Affirm™ VPIII
Microbial
Identification Test BD ProEx™ C
Reagent Programs in Development
[spacer image]
Non-Gyn
[spacer image]
Product Inserts
[spacer image]
MSDS Documents
[spacer image]
Resources
[spacer image]
Contact Us
[spacer image]
Labs Main Page
[spacer image]
TriPath Home
[spacer image]
[spacer image]

Did you know?
[spacer image] Fairleigh Dickinson was issued a patent for the BD Luer-Lok™ syringe in 1925. Learn more about BD's history » [spacer image]
[spacer image]


Molecular Oncology
Email Page Print
[spacer image]
BD ProEx™ C Reagent

BD ProEx™ C ICC   |  BD ProEx™ C IHC   |  Aberrant S-Phase Induction   |  Slide Atlas   Publications   |  Other Products   |  Order   |  Reimbursement   |  FAQs   |  Events

Slide Atlas: Tissue

Tissue Control T1: History of Squamous Cell Carcinoma. (50X) Tissue Control T2:
History of CIN 3. (200X)
Cervical biopsy sample Cervical biopsy sample
Cervical biopsy sample. Positive for Aberrant S-Phase Induction. Immunohistochemistry using BD SureDetect™ reagents. Cervical biopsy sample. Positive for Aberrant S-Phase Induction. Immunohistochemistry using BD SureDetect™ reagents.
 
[spacer image]
[spacer image] [spacer image] [spacer image]
[spacer image] [spacer image] [spacer image]
[spacer image]
Site Map
Terms & Conditions | Permission Request | Trademarks
BD Worldwide
BD
1 Becton Drive
Franklin Lakes, NJ USA 07417
201.847.6800
Unless otherwise noted, BD, BD Logo and all other trademarks are property of Becton, Dickinson and Company. © 2010 BD